SCHEMBL8291349

SCHEMBL8291349

CCOC(=O)C1CC2CC(=CP(=O)(OCC)OCC)CCC2CN1C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6611656 0.85 ALDH1A1 (0.30)
SCHEMBL6611658 0.85 ALDH1A1 (0.30)
SCHEMBL8300387 0.82 IDH1 (0.34)
SCHEMBL8300389 0.82 IDH1 (0.34)
SCHEMBL25475425 0.80 ALDH1A1 (0.32)
SCHEMBL3302863 0.80 ALDH1A1 (0.32)
SCHEMBL7058824 0.80 ALDH1A1 (0.32)
SCHEMBL8291352 0.80 SMYD3 (0.33)
SCHEMBL6606249 0.79 ALDH1A1 (0.34)
SCHEMBL6604771 0.78 FKBP1A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0658545-B1 Decahydro-isoquinoline derivatives LILLY CO ELI (US) 1999-09-29 EP disclosed
EP-0383504-B1 Decahydro isoquinoline derivatives, process for their preparation and use as medicines LILLY CO ELI (US) 1995-07-19 EP disclosed
EP-0658545-A1 Decahydro-isoquinoline derivatives ELI LILLY AND COMPANY (US) 1995-06-21 EP disclosed
EP-0383504-A2 Decahydro isoquinoline derivatives, process for their preparation and use as medicines ELI LILLY AND COMPANY (US) 1990-08-22 EP disclosed
US-4902695-A ISOQUINOLINE DERIVATIVES; NERVOUS SYSTEM DISORDERS ELI LILLY AND COMPANY (US) 1990-02-20 US disclosed